| Literature DB >> 24215932 |
Calixto-Hope Lucas1, Mathilde Calvez2, Roshni Babu3, Amanda Brown4.
Abstract
The anti-NeuN antibody has been widely used for over 15 years to unambiguously identify post-mitotic neurons in the central nervous system of a wide variety of vertebrates including mice, rats and humans. In contrast to its widely reported nuclear localization, we found significantly higher NeuN reactivity in the cytoplasm of neurons in brain sections from HIV-infected individuals with cognitive impairment compared to controls. The protein target of anti-NeuN antisera was recently identified as the neuron-specific RNA splicing factor, Rbfox3, but its significance in diseases affecting the brain has not been previously reported. RNA splicing occurs in the nucleus hence, the altered localization of RbFox3 to the cytoplasm may lead to the downregulation of neuronal gene expression.Entities:
Keywords: Gene expression; HIV-associated neurocognitive disorders; NeuN; Neurodegeneration; Rbfox3; Splicing
Mesh:
Substances:
Year: 2013 PMID: 24215932 PMCID: PMC3880598 DOI: 10.1016/j.neulet.2013.10.037
Source DB: PubMed Journal: Neurosci Lett ISSN: 0304-3940 Impact factor: 3.046